3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor
Conditions
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Obesity, Morbid
1
Neoadjuvant Chemoimmunotherapy
1
Lymphatic Metastasis
1
Invasive Breast Carcinoma
1
Genital Diseases, Female
1
Gastrointenstinal Stromal Tumor (GIST)
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
40
Paclitaxel
35
Carboplatin
28
pembrolizumab
21
Cyclophosphamide
15
Specimen Handling
14
Cisplatin
13
olaparib
11
Blood Specimen Collection
11
niraparib
10
fludarabine
10
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
liposomal doxorubicin
8
Topotecan
8
Taxes
8
Gemcitabine
8
Biopsy
8
Fulvestrant
7
Doxorubicin
6
cemiplimab
5
abemaciclib
5
Surveys and Questionnaires
5
Standard of Care
5
Injections
5
Fluorouracil
5
Cytoreduction Surgical Procedures
5
trastuzumab deruxtecan
4
mirvetuximab soravtansine
4
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Neoplasms
×
Robotic Surgical Procedures
×
Clear all
No trials found.